1D
🌎 The World's largest Index of Cryptoassets. Get listed →
InnovativeBioresearchClassic (INNBCL)INNBCL
$0.000000000555
InnovativeBioresearchClassic (INNBCL)
INNBCL Price
$0.000000000555
Rank
—
Market Cap (24H)
Unknown
Volume (24H)
Unknown
Circulating Supply
Transp. Vol.
Grade
1H1D1W1M1Y
InnovativeBioresearchClassic logo
INNBCL
United States Dollar logo
USD
ETH0x0cc9f...ed851cf
ETH
Verify address & DYOR
Contract
ETH0x0cc9f...ed851cf
ETH
Verify address w/ multiple resources & DYOR
Blockchain
Websitehttps://www.innovativebioresearch.com/
CommunityTwitterTelegramFacebook
Innovative Bioresearch Ltd is a private biotech company. Its work is focused on the innovations in the domain of HIV, c...Read more

InnovativeBioresearchClassic Price (INNBCL)

INNBCL Daily Performance

As of today, the last reported INNBCL price is $0.000000000555. InnovativeBioresearchClassic's last market cap was unknown. 24 hour INNBCL volume is unknown. It has a market cap rank of unknown and max supply of 2,294,442,925,301. InnovativeBioresearchClassic is traded on exchanges. InnovativeBioresearchClassic had an all-time high of $0.006022 almost 3 years ago. Over the last day, InnovativeBioresearchClassic has had 0% transparent volume and has been trading on 11 active markets with its highest volume trading pairs being .

Want Daily INNBCL Price Updates?

  • Delivered when you want
  • Track additional assets & more
Privacy GuaranteedSecure Submission

This site is protected by reCAPTCHA and the Google  Privacy Policy and  Terms of Service apply.

InnovativeBioresearchClassic Statistics

InnovativeBioresearchClassic Price (24hr)$0.000000000555 (0.00%)
Market Cap
Trading Volume (24hr)Unknown
Transparent Vol. (24hr)
Unknown
Transparency GradeUnknown
Circulating SupplyUnknown
All-Time High
$0.006022-100.00%
7D Price Prediction
N/A

Price

$0.000000000555
Price ChangeUnknown

All-Time High

$0.006022
Date of ATH
Days Since ATH
% of ATH0.00%
Price vs ATH

About InnovativeBioresearchClassic

Innovative Bioresearch Ltd is a private biotech company. Its work is focused on the innovations in the domain of HIV, cancer and regeneration research. They develop a new therapeutic strategy, and from their point of view, it has all the chances to be adopted by a great number of clinicians all over the world. In their work, these specialists face a great number of problems, such as the necessity to coordinate the doctors in different countries and the lack of access to the data on previous trials and research. Today these research procedures are time-consuming, tiresome, and each case may have individual features.

The decentralized database seems to be a good solution to this problem. With the platform developed by Innovative Bioresearch, the clinical data will be stored and accessed via blockchain to avoid the troubles associated with the traditional approach. The solution will be realized with the help of the “You’re not alone” application, which is on the stage of development at the time of writing. The app will be used to get access tot he clinical data and operate on-the-fly, to analyze statistical information and treatment profiles. Another option is related to social interaction. It will demonstrate the changes in Innovative Bioresearch’s AIDS cure research project, giving the base for community creation. It was reflected in the app’s name.

Innovative Bioresearch tokens

The project suggests two types of tokens: INNBC and INNBCL. INNBC is designed for the development of cancer and regeneration programs, while INNBCL is designed for the support AIDS research project.

The InnovativeBioresearchClassic (INNBCL) is a utility token, which is based on the ERC-20 standard. It is not conceived as a company’s share, but it can be sold or bought on a number of exchanges (Mercatox, IDEX, CREX24, etc.). INNBCL token holders may get higher rewards in the future than INNBC holders as the supported markets are different.

According to the official website, INNBCL will be spent on access to all medical products, treatments, and services of the company. The token is also backed by the value of the cars from so-called JDM ONLINE GARAGE. JDM stands for “Japanese Domestic Market”, and according to the official website, some JDM importers are the project partners. They will give a chance to INNBCL holders to buy these cars with discounts when the online garage is launched.

The holders can store their INNBCL tokens in any third-party wallet compatible with Ethereum. The project’s partner Archos, a French technology company, offers 20% discounts on their hardware wallets to the INNBCL token holders.

ICO details

There is no reliable and verifiable information on how the initial coin offering was conducted. Though the official website claims that the token sale was completed in June 2018, it is not explained exactly which of two tokens is meant and no further details are provided. All the information from specialized websites refers to the ICO for the sister-coin, INNBC. The maximum supply is also unknown.

Innovative Bioresearch team and partners

The company was founded in 2014. Initially, it was located in Italy, and in 2018 it was moved to the UK. The owner and Chief Scientific Officer of Innovative Bioresearch is Jonathan Fior, a scientist and researcher, who specializes in HIV treatment. He is a Bachelor of Medical Biotechnology, and he graduated from the University of Milan.

Two other major team members are Davide Bosetti (a Social Media Manager) and Alessandro Gatti (a Chief Legal Officer). No data on their previous careers is available on the internet.

According to the official website, the company has two strategic partners, WalkyFit, the innovative Functional App, which distributes different tokens depending on the physical activity of the user, and Archos already mentioned above. No information on JDM importer partners can be found.

Read More

InnovativeBioresearchClassic Markets

(Top 10)
Loading...

InnovativeBioresearchClassic Historical Data

(Past 7 Days)
Loading...

Today's INNBCL / InnovativeBioresearchClassic News for March 25, 2023

Loading...

Similar Assets

(By Market Cap)
Loading...